Further analyses should be performed to assess whether p53 is trapped in the cytoplasm by IκB-α in challenging Philadelphia positive scenarios, such Ph+-ALL or Tyrosine Kinase Inhibitor (TKI)-resistant CML. This evidence concerns the gene TP53 and chronic myelogenous leukemia, BCR-ABL1 positive.